Paratek (formerly Transcept Pharmaceuticals)

Acquired

Boston, United States · Founded 1996 · $140.0M raised

Employees
201–500
Founded
1996
Business Model
B2B
Total Funding
$140.0M
Last Round
$140.0M Convertible NoteApr 2018
Rounds
1
Acquisition Date
Jun 2023

About

Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychiatry and sleep medicine

Summary

Paratek (formerly Transcept Pharmaceuticals) is a Biotech company based in Boston, United States, founded in 1996. It has raised $140.0M in total across 1 round, most recently a $140.0M Convertible Note round in Apr 2018. Investors include Gurnet Point Capital, Novo Holdings A/S and Aisling Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

AcquisitionJun 2023
$462.0M

Sign up to see all 5 rounds

IPO through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Paratek (formerly Transcept Pharmaceuticals) on Indexed.vc
<a href="https://indexed.vc/companies/transcept-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/transcept-pharmaceuticals" alt="Paratek (formerly Transcept Pharmaceuticals) on Indexed.vc" width="260" height="76" /></a>